|
YBX1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.082400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.713200E-01 |
| Normal-vs-Stage2 |
2.799600E-01 |
| Normal-vs-Stage3 |
6.679600E-01 |
| Normal-vs-Stage4 |
5.378400E-02 |
| Stage1-vs-Stage2 |
1.651010E-01 |
| Stage1-vs-Stage3 |
7.277400E-01 |
| Stage1-vs-Stage4 |
4.394400E-02 |
| Stage2-vs-Stage3 |
1.765800E-01 |
| Stage2-vs-Stage4 |
1.347830E-02 |
| Stage3-vs-Stage4 |
1.268220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.662200E-01 |
| Normal-vs-AfricanAmerican |
1.013840E-01 |
| Normal-vs-Asian |
3.605800E-01 |
| Caucasian-vs-AfricanAmerican |
1.835630E-02 |
| Caucasian-vs-Asian |
5.876000E-01 |
| AfricanAmerican-vs-Asian |
1.709350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.641800E-01 |
| Normal-vs-Female |
7.897200E-01 |
| Male-vs-Female |
1.765750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.669560E-01 |
| Normal-vs-Age(41-60Yrs) |
5.794400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.022800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.275800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.810400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.924760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.343550E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.735000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.907830E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.497600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.359200E-01 |
| Normal-vs-Grade 2 |
6.467200E-01 |
| Normal-vs-Grade 3 |
9.940200E-01 |
| Normal-vs-Grade 4 |
7.278400E-02 |
| Grade 1-vs-Grade 2 |
9.673000E-01 |
| Grade 1-vs-Grade 3 |
8.744200E-01 |
| Grade 1-vs-Grade 4 |
2.422600E-01 |
| Grade 2-vs-Grade 3 |
5.612000E-01 |
| Grade 2-vs-Grade 4 |
1.098810E-01 |
| Grade 3-vs-Grade 4 |
6.062300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.731400E-01 |
| Normal-vs-ccB subtype |
3.165400E-01 |
| ccA subtype-vs-ccB subtype |
1.404800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.928600E-01 |
| Normal-vs-N1 |
1.065750E-01 |
| N0-vs-N1 |
1.892770E-01 |
|
|
